APM

APTORUM GROUP
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.750
-0.040
-1.06%
Closed 16:00 08/03 EDT
OPEN
3.790
PREV CLOSE
3.790
HIGH
4.036
LOW
3.560
VOLUME
95.64K
TURNOVER
--
52 WEEK HIGH
22.42
52 WEEK LOW
1.660
MARKET CAP
112.44M
P/E (TTM)
-5.7436
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average APM stock price target is 13.00 with a high estimate of 15.00 and a low estimate of 11.00.

EPS

APM News

More
Aptroum Group Reports Receives Approval For Listing On Euronext Paris Exchange
Benzinga · 07/17 10:22
Here's What Aptorum Group Limited's (NASDAQ:APM) Shareholder Ownership Structure Looks Like
Simply Wall St. · 07/03 17:56
Analysts Recommend Catching These 2 Falling Knives
GuruFocus.com · 06/25 16:25
Aptorum Group Limited Strengthens Its Presence in the US With the Appointment of Dr. Kira Sheinerman
Aptorum Group Limited (NASDAQ:APM), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced the appointment of Dr. Kira Sheinerman as the senior strategic consultant based in New York
Business Wire · 06/15 12:00
Aptorum Group Interview to Air on Bloomberg International on the RedChip Money Report
Business Wire · 05/29 13:00
Aptorum Group Limited to Present at the Infectious Disease Virtual Conference
Business Wire · 04/29 13:00
Aptorum Group Limited Reports 2019 Fiscal Year End Financial Results and Provides Business Update
Business Wire · 04/29 13:00
Aptorum Group FY19 Net Loss $20.1M vs $15.1M Loss In FY18
Aptorum Group (NASDAQ:APM) will report on Q4 2019.
Benzinga · 04/29 12:08

Industry

Pharmaceuticals
+1.51%
Pharmaceuticals & Medical Research
+2.08%

Hot Stocks

Symbol
Price
%Change

About APM

Aptorum Group Limited is a company mainly engaged in the production and sale of pharmaceuticals. Along with subsidiaries, the Company operates its business through three segments. The Therapeutics segment is involved in the production and sale of drug molecules. It also develops technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology and other disease areas. The Non Therapeutic segment is involved in the development of surgical robotics and medical devices. In addition, it is also involved in the provision of healthcare and clinic services, as well as operation of a medical center under the name of Talem.
More

Webull offers kinds of Aptorum Group Ltd stock information, including NASDAQ:APM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading APM stock methods without spending real money on the virtual paper trading platform.